FDA Recalls Ethinyl Estradiol Bulk Drug Due to Quality Assurance Failures
The FDA is recalling bulk Ethinyl Estradiol Micronized manufactured by Qinhuangdao Zizhu Pharmaceutical due to cGMP deviations and lack of quality assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, which corresponds to a Severe rating (Score 4) under the provided rubric, as it involves a product that may cause temporary or medically reversible health consequences.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for Ethinyl Estradiol Micronized, USP, Bulk, which is intended for prescription compounding. The product is manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, located in Qinhuangdao, China, and carries the NDC 44132-002-05.
The recall was initiated because the product was found to have Current Good Manufacturing Practice (cGMP) deviations and a lack of quality assurance. The affected batches range from 73801506007 to 73801603001, with expiration dates between May 31, 2017, and January 15, 2018. The product was distributed to New York, Texas, South Carolina, Colorado, Minnesota, and New Jersey.
Healthcare professionals and compounding pharmacies should stop using the affected product and contact the recalling firm for instructions on return or disposal. Consumers should not use this bulk ingredient for self-medication and should consult their healthcare provider if they have questions regarding prescriptions filled with this specific ingredient.
The recalled product
- Product
- Ethinyl Estradiol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China (NDC 44132-002-05)
- Manufacturer
- Qinhuangdao Zizhu Pharmaceutical, Co.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch 73801506007 to 73801603001
- exp 5/31/2017 through 1/15/2018
Distribution
Part of a larger recall action
This product is one of 7 recalled by Qinhuangdao Zizhu Pharmaceutical, Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Qinhuangdao Zizhu Pharmaceutical, Co.
See all →- ModerateFDA Recalls Levonorgestrel Bulk Drug Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
- SevereFDA Recalls Estrone Micronized Bulk Drug Due to Quality Assurance Failures
FDA (Drugs) · 2017-04-19
- SevereFDA Recalls Testosterone Micronized Bulk Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
- ModerateFDA Recalls Estradiol Micronized Bulk Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
- ModerateFDA Recalls Estriol Micronized Bulk Drug Due to Quality Assurance Failures
FDA (Drugs) · 2017-04-19
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14